TX-45(Tectonic Therapeutic)

N/A

Report date: 2026/03/30 20:02:02

Base Information

Drug NameTX-45(Tectonic Therapeutic)
Drug Alias NameTX45(Tectonic Therapeutic)TX-000045
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionG-protein coupled receptor antagonistsRelaxin receptor 1 agonists
TargetsG-protein coupled receptorRelaxin receptor 1
Therapy Area/IndicationsTelangiectasia, Hereditary HemorrhagicHeart Failure, DiastolicHeart Failure +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumArmeniaBulgaria +[16] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTectonic Therapeutic Inc
China Registration ClassN/A

Develop Information

Active CompaniesTectonic Operating Company IncTectonic Therapeutic Inc
Inactive CompaniesN/A
Active IndicationsTelangiectasia, Hereditary HemorrhagicHeart Failure, DiastolicHeart Failure +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A